JP2023503898A5 - - Google Patents
Info
- Publication number
- JP2023503898A5 JP2023503898A5 JP2022529452A JP2022529452A JP2023503898A5 JP 2023503898 A5 JP2023503898 A5 JP 2023503898A5 JP 2022529452 A JP2022529452 A JP 2022529452A JP 2022529452 A JP2022529452 A JP 2022529452A JP 2023503898 A5 JP2023503898 A5 JP 2023503898A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- group
- aryl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025202023A JP2026032104A (ja) | 2019-11-24 | 2025-11-21 | フルベストラントのプロドラッグ |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921047986 | 2019-11-24 | ||
| IN201921047986 | 2019-11-24 | ||
| IN202021029084 | 2020-07-08 | ||
| IN202021029084 | 2020-07-08 | ||
| PCT/IB2020/061065 WO2021100029A2 (en) | 2019-11-24 | 2020-11-24 | Prodrugs of fulvestrant |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025202023A Division JP2026032104A (ja) | 2019-11-24 | 2025-11-21 | フルベストラントのプロドラッグ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023503898A JP2023503898A (ja) | 2023-02-01 |
| JP2023503898A5 true JP2023503898A5 (cg-RX-API-DMAC7.html) | 2023-12-18 |
Family
ID=75980095
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022529452A Pending JP2023503898A (ja) | 2019-11-24 | 2020-11-24 | フルベストラントのプロドラッグ |
| JP2025202023A Pending JP2026032104A (ja) | 2019-11-24 | 2025-11-21 | フルベストラントのプロドラッグ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025202023A Pending JP2026032104A (ja) | 2019-11-24 | 2025-11-21 | フルベストラントのプロドラッグ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230137764A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4061376A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023503898A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115151260A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020386864A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3162182A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021100029A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024538818A (ja) * | 2021-10-29 | 2024-10-23 | カシーヴ バイオサイエンシズ,リミテッド・ライアビリティ・カンパニー | 乳癌治療用注射可能な医薬組成物 |
| CN117957238A (zh) * | 2021-12-06 | 2024-04-30 | 江苏亚虹医药科技股份有限公司 | 氟维司群衍生物及其制备方法和医药用途 |
| CN118871116A (zh) * | 2021-12-06 | 2024-10-29 | 卡希夫生物科学有限公司 | 用于治疗癌症的化合物 |
| CN114716496B (zh) * | 2022-04-29 | 2024-04-02 | 香港中文大学(深圳) | 氟维司群衍生物及氟维司群衍生物制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2176208T3 (en) * | 2007-07-30 | 2015-04-27 | Zynerba Pharmaceuticals Inc | Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof |
| US20140079636A1 (en) * | 2012-04-16 | 2014-03-20 | Dinesh U. Chimmanamada | Targeted therapeutics |
| US20160060288A1 (en) * | 2013-04-18 | 2016-03-03 | Xi'anlibang Pharmaceutical Technology Co., Ltd. | Ester derivatives of 7-alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-estra-1,3,5(10)-triene-3,17beta-diol having anticancer activity and preparation method thereof |
| US20160038439A1 (en) * | 2013-04-18 | 2016-02-11 | Xi'anlibang Pharmaceutical Technology Co., Ltd. | Use of 7-a-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-estra-1,3,5(10)- triene-3,17B-diol and derivatives thereof |
| CN103421069A (zh) * | 2013-05-23 | 2013-12-04 | 中国海洋大学 | 氟维司群磷酸酯衍生物及其制备方法和应用 |
| EP3738594A1 (en) * | 2013-09-10 | 2020-11-18 | Madrigal Pharmaceuticals, Inc. | Targeted therapeutics having an hsp90 ligand as binding moiety |
| WO2019050850A1 (en) * | 2017-09-05 | 2019-03-14 | Primetime Life Sciences, Llc | BIGUANIDINE DERIVATIVES OF THERAPEUTIC AGENTS, AND PREPARATION METHODS AND METHODS OF USING SAME |
| JP7384903B2 (ja) * | 2018-05-24 | 2023-11-21 | ケーアイ ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー | フルベストラントのプロドラッグ |
-
2020
- 2020-11-24 AU AU2020386864A patent/AU2020386864A1/en active Pending
- 2020-11-24 WO PCT/IB2020/061065 patent/WO2021100029A2/en not_active Ceased
- 2020-11-24 JP JP2022529452A patent/JP2023503898A/ja active Pending
- 2020-11-24 US US17/779,015 patent/US20230137764A1/en active Pending
- 2020-11-24 CA CA3162182A patent/CA3162182A1/en active Pending
- 2020-11-24 EP EP20891095.0A patent/EP4061376A4/en active Pending
- 2020-11-24 CN CN202080093658.5A patent/CN115151260A/zh active Pending
-
2025
- 2025-11-21 JP JP2025202023A patent/JP2026032104A/ja active Pending